Is TEVA stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-22, Teva Pharmaceutical Industries Limited (NYSE: TEVA) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 53/100 at a spot price of $38.53 (-8.76% 1D, market cap $44.96B). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 10/20, SEC Balance-Sheet Forensics 12/20, FRED Macro Regime Fit 10/20, and Executive Insider Alignment 12/20. Across 1015 tracked Health Care issuers, TEVA ranks #200 in composite RQD confidence.